CLDN1 and breast carcinoma: Therefore, the expression of high claudin 1 levels in the BLBC subtype, particularly in women over 55 years of age suggests that these patients may warrant more aggressive treatment as their breast cancer may be more migratory resulting in a tendency to move away from the primary location.